Aug. 17, 2023

Physicians who participated in the 2022 Merit-based Incentive Payment System (MIPS) can now review their final MIPS score and 2024 payment adjustment information. Participant data is available on the Centers for Medicare and Medicaid Services (CMS) website Quality Payment Program (QPP) portal. To access this information, users must sign in using their Health Care Quality Information Systems (HCQIS) Access Roles and Profile (HARP) credentials and click on the “View Feedback” link on the homepage.

Participants in the MIPS program are encouraged to carefully review their information for accuracy. Participants who believe there may be an error in their final score or payment adjustment must submit a targeted review request by Oct. 9 (reviews may be requested using the “Targeted Review” link after logging on to the QPP Portal).

CMS seeks feedback from physicians who participated in 2022 MIPS and have viewed their scoring feedback information. This link takes participants interested in providing feedback to the survey.

If you have questions or would like more information about MIPS participation scoring, contact Zach Smith, American College of Radiology® Senior Quality Programs Specialist.


Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more